Oxymetazoline nasal Pregnancy and Breastfeeding Warnings

Brand names: Afrin, Afrin Allergy Sinus Nasal Spray, Afrin NoDrip Extra Moisturizing, Afrin NoDrip Severe Congestion, Afrin NoDrip Sinus, Afrin Original, Afrin Severe Congestion, Afrin Sinus, CVS Health Sinus Relief, Dristan 12 Hour Nasal Spray, Duration, Four-Way Nasal Spray, Genasal, Mucinex Sinus-Max Full Force, NRS Nasal, Neo-Synephrine 12 Hour, Nostrilla, Oxyfrin, Oxymeta-12, Vicks Sinex 12-Hour Decongestant Nasal Spray, Vicks Sinex 12-Hour Decongestant UltraFine Mist, Vicks Sinex Moisturizing 12-Hour Decongestant UltraFine Mist, Vicks Sinex Severe Nasal Spray, Zicam Extreme Congestion Relief, Zicam Sinus Relief

Medically reviewed by Drugs.com. Last updated on Dec 21, 2023.

Oxymetazoline nasal Pregnancy Warnings

Use should be avoided.

US FDA pregnancy category: Not assigned

Animal studies have not been conducted. There are no adequate and well-controlled studies in pregnant women.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.

See references

Oxymetazoline nasal Breastfeeding Warnings

Use should be avoided.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer